Item
CAFFEINE ANYHYDROUS USP KOSHER CSPC (3093629 210 04M)
Food Ingredient
Locations
| Location name | Address |
|---|---|
| CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | NO. 36 FUQIANG WESTERN ROAD LUANCHENG COUNTY SHIJIAZHUANG CITY, HEBEI PROVINCE 0 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| CoA Sample | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | 3093629 CAFFEINE ANYHYDROUS USP KOSHER Lot 1032310410 .pdf | 10/11/2023 | 10/10/2025 |
| Allergens | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Allergen Statement.pdf | 4/6/2023 | 4/5/2025 |
| Lot Code | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Batch Number Statement.pdf | 4/6/2022 | 4/5/2025 |
| BSE - TSE | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | BSE TSE FREE STATEMENT.pdf | 4/6/2022 | 4/5/2025 |
| Product Specification Sheet | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Caffeine specificationBP2016、USP39、EP8.0.pdf | 11/17/2021 | 11/16/2024 |
| Country of Origin | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Country of Origin Statement.pdf | 4/6/2022 | 4/5/2025 |
| Gluten | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Gluten Free Statement.pdf | 4/6/2023 | 4/5/2025 |
| GMO | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | GMO Free Statement.pdf | 6/6/2023 | 6/5/2025 |
| GRAS/NDI/ODI Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | GRAS Statement.pdf | 4/6/2022 | 4/5/2025 |
| HACCP | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | HACCP plan for Caffeine.pdf | 2/9/2022 | 2/8/2025 |
| Halal | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | HALAL-2023.pdf | 3/15/2023 | 3/14/2027 |
| Heavy Metal | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Heavy Metal Statement.pdf | 4/6/2023 | 4/5/2025 |
| Label Claims | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Label statement.pdf | 4/6/2023 | 4/5/2025 |
| Label Sample | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | label-caffeine.pdf | 9/18/2024 | 9/18/2025 |
| FSVP Assessment Form | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | MIFI FSVPI Acknowledgement CSPC Innovation.pdf | 6/13/2024 | 6/13/2025 |
| No Animal Ingredient Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Non-Animal Origin Statement.pdf | 6/7/2024 | 6/7/2025 |
| EtO Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Non-ETO and non-chemical sterilization statement.pdf | 4/6/2023 | 4/5/2025 |
| Irradiation Status Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Non-irradiated Statement.pdf | 4/6/2023 | 4/5/2025 |
| Natural | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Non-Natural Statement.pdf | 6/7/2024 | 6/7/2025 |
| Letter of Guarantee | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | NotApplicable_LetterofGuarantee.pdf | 7/11/2023 | 7/10/2025 |
| Organic | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | NotApplicable_Organic.pdf | 9/18/2024 | 9/18/2026 |
| Nutrition | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Nutritional Information-caffeine.pdf | 4/6/2022 | 4/5/2025 |
| Kosher | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | OUV2-D828D85.pdf | 9/4/2024 | 8/31/2025 |
| Food Contact Packaging Certificate of Compliance | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Package Material Statement-食品.pdf | 6/8/2023 | 6/7/2025 |
| Pesticide | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Pesticides Free Statement.pdf | 4/6/2023 | 4/5/2025 |
| Phthalate Esters Letter | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Phthalates Free Statement.pdf | 6/7/2024 | 6/7/2025 |
| HACCP Process Flow Diagram | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Process Flow Chart of Caffeine -CCP.pdf | 6/6/2023 | 6/5/2025 |
| Ingredient Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | product composition statement.pdf | 4/6/2022 | 4/5/2025 |
| California Prop. 65 | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Prop 65 Statement.pdf | 4/6/2023 | 4/5/2025 |
| Residual Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Residual Solvent Statement.pdf | 4/6/2024 | 4/6/2025 |
| Safety Data Sheet (SDS) | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | SDS-Caffeine.pdf | 6/9/2022 | 6/8/2025 |
| Animal Testing Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | SDS-Caffeine.pdf | 9/14/2023 | 9/13/2025 |
| Sewage Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Sewage Sludge Free Statement.pdf | 4/6/2023 | 4/5/2025 |
| Shelf Life | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Storage conditions and Expiry date.pdf | 4/6/2022 | 4/5/2025 |
| Suitability Requirements | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | Suitability Statement.pdf | 6/7/2022 | 6/6/2025 |
| WADA/NSF/NFL Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | WADA banned substances Free Statement.pdf | 4/6/2023 | 4/5/2025 |
